- Targeting PP2A activates AMPK signaling to inhibit colorectal cancer cells.
Targeting PP2A activates AMPK signaling to inhibit colorectal cancer cells.
Oncotarget (2017-12-10)
Cuiping Dai, Xuning Zhang, Da Xie, Peipei Tang, Chunmei Li, Yi Zuo, Baofei Jiang, Caiping Xue
PMID29221169
RÉSUMÉ
LB-100 is a novel PP2A inhibitor. Its activity in human colorectal cancer (CRC) cells was tested. The
MATÉRIAUX
Référence du produit
Marque
Description du produit